The elevated expression of ANXA2 can contribute to the tumor progression in estrogen receptor (ER) negative breast cancer cell lines [57]; pancreatic tumor progression can be inhibited by blocking VCAM1 [58]. Here, VCAM1 is linked to breast carcinoma.